3D MOLECULAR DOCKING COMBINED WITH AI-DRIVEN VIRTUAL SCREENING TO REPURPOSE FDA-APPROVED DRUGS FOR RARE NEURODEGENERATIVE DISEASES. Int. J. Exp. Biol. [Internet]. 2024 Jun. 30 [cited 2026 Apr. 30];2(01):50-73. Available from: https://ijeb.online/index.php/IJEB/article/view/23